Search for Clinical Trial Results

Sponsored By

Enteropathy-Associated T-Cell Lymphoma - 18 Studies Found

Status Study
Withdrawn Study Name: High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
Condition:
  • Lymphoma
  • Small Intestine Cancer

Date: 2008-04-30
Interventions:
  • Drug: carmustine
  • Drug: cyclophosphamide
Recruiting Study Name: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Condition:
  • Lymphoma, Large-Cell, Anaplasitc
  • Hodgkin Disease
  • Lymphoma,
    Date: 2017-02-09
    Interventions:
    • Biological: Anti-CD30-CAR T cells

Recruiting Study Name: Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
Condition:
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Anaplastic Large Cell Lymphoma, ALK-Positive Date: 2015-09-24
    Interventions:
    • Drug: Cyclophosphamide Given I
Not yet recruiting Study Name: Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Condition:
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Hepatosplenic T-Cell Lymphoma
  • Other: Laboratory Biomarker Analysis

Recruiting Study Name: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
Condition:
  • Peripheral T-Cell Lymphoma
  • Angioimmunoblastic T Cell Lymphoma
  • Drug: CEOP/IVE/GDP chemotherapy regimen

Recruiting Study Name: CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Condition:
  • ALK-negative Anaplastic Large Cell Lymphoma
  • Peripherial T Cell Lymphoma,Not Otherwise Specif
    Date: 2012-12-04
    Interventions:
    • Drug: Cyclophosphamide 750mg/m2

Recruiting Study Name: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)
Condition:
  • T-cell Lymphoma
  • Angioimmunoblastic T-cell Lymphoma
  • Hepato-
    Date: 2015-10-26
    Interventions: Drug: Brentuximab vedotin study drug given intravenously to determine efficacy in study diseases
Not yet recruiting Study Name: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
Condition:
  • Adult T-Cell Leukemia/Lymphoma
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Drug: Brentuximab Vedotin Give
Recruiting Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Condition:
  • Aggressive Non-Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Dietary Supplement: Cholecalciferol

Recruiting Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Nasal Type Extranodal NK/T-Cell Lymphoma
  • Adult T-Cell Leukemia/Lymphoma
  • Date: 2016-01-08
    Interventions:
    • Other: Laboratory Biomarker Analysis

Next >>>